{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-062870","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2022-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.806708+00:00","generated_at":"2026-06-25T09:26:24.633302+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"PowerUp Acquisition Corp. appoints Kyle Campbell as independent Class III director","bullets":["Kyle Campbell appointed as Class III director effective May 16, 2022.","Board determined Campbell is independent under Nasdaq and SEC rules; joins Audit Committee.","Campbell is senior analyst at Greenhaven Road Capital and former CFO of a family office.","No family relationships or transactions with the company exist."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-062870","json":"https://secwatch.observer/filing/0001104659-22-062870.json","markdown":"https://secwatch.observer/filing/0001104659-22-062870.md","text":"https://secwatch.observer/filing/0001104659-22-062870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/0001104659-22-062870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/tm2215972d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T09:26:24.633302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d45c680192","claim":"Kyle Campbell was appointed as Class III director at Aspire Biopharma Holdings, Inc..","evidence_excerpt":"Effective May 16, 2022, the board of directors (the “Board”) of PowerUp Acquisition Corp., a Cayman Islands exempted company (the “Company”), appointed Kyle Campbell, as a Class III director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/0001104659-22-062870-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}